Clinical Leader Webinar

  1. The Importance Of Engaging A Patient’s Support System During A Clinical Trial

    Learn how innovative mobile technology helps clinical trial participants stay engaged and compliant through the empowerment of the patient’s loved ones. Speaker, Stephen J. Freedland, M.D. (Urologist at Cedars Sinai DEPT of Surgery), presents a compelling case discussion on the importance of patient compliance and market approval, followed by Chief Medical Officer of Parallel 6, Brad Pruitt, M.D., MBA, who demonstrates the new Clinical Reach™ companion app followed by an in-depth Q&A session covering clinical use and various trial applications.

  2. eCOA And Equivalence Testing: New Evidence From Meta-Analysis

    The evaluation of the compatibility between scores from an electronic version of a paper-based questionnaire, better known as equivalence testing, is usually taken as a requirement for ensuring that data from electronic versions of patient reported outcomes does not vary from that captured on paper. This webinar discusses the results of a recently published meta-analysis which examined all published equivalence tests from 2007 to 2013. This webinar discusses equivalence testing, how the current meta-analysis run, and what the results mean in context of the field of eCOA.

  3. Using ePRO With Smart Devices

    Interest in using electronic patient reported outcomes (ePRO) on smart devices is on the rise. In this webinar, Emily Cantrell and Becky Baggett will share lessons learned working on a large phase 3 pain study that utilizes ePRO on tablet devices.

  4. eSource Data Capture Simplified — Uncover Time and Cost Saving Possibilities

    This webinar will discuss some of the benefits of an eSource approach, which include eliminating double entry of data and the need for source data verification, reducing the need for data queries, and optimizing monitoring time. 

  5. An Intelligent Approach to Risk-Based Monitoring

    How People, Process and Tools can Improve Clinical Trial Quality

  6. Synergism: Partnering on EDC Technology Transfer

    Join this webinar and hear about different EDC sourcing models − the traditional EDC software approach and EDC technology transfer – and find out what level of control in studies is right for you.

  7. RBM-Enabling Technology: Analytics with Action

    In this webinar participants will explore technology considerations in depth with Trevor McCaw, co-developer of BioClinica's Compass intelligent monitoring solution. Trevor will explain how to tell if an RBM tool is truly framed around risk and quality principles using Compass as a demonstration platform.

  8. Modern Randomization: A Sampling of Current Schemes using IRTs

    Patient randomization is critical to running all blinded clinical trials, but not all randomization methods can meet the needs of modern studies. Complex protocols that include multiple treatment arms, adaptive designs, and inconsistent allocation ratios require advanced interactive response technology (IRT) randomization engines for proper trial execution. This increased statistical power brings with it a higher risk of error and can impact drug supply predictability, making it more important than ever to find the right IRT system for your trial.

  9. IRT: More Gain, Less Pain - Is IRT Technology Transfer Right for You?

    Join this webinar and hear about different IRT sourcing models − the traditional IRT software approach and IRT technology transfer – and find out what level of control in studies is right for you.

  10. Risk-Based Monitoring and Related Initiatives – A Data Management Professional’s Perspective

    In this webinar, Jonathan Andrus will bring attendees up to speed on these three organizations that are helping to reshape the clinical trials landscape. By attending, you will gain valuable insights on how member organizations, sponsors, CROs, regulators, academia, societies, institutes, and others are collaborating in new ways to improve the conduct of clinical trials. The presentation will identify the major players, examine their key initiatives, and review what they have achieved as well as what additional changes are on the horizon.